InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 09/28/2012

Re: Fred Kadiddlehopper post# 4632

Thursday, 07/21/2016 7:00:47 PM

Thursday, July 21, 2016 7:00:47 PM

Post# of 8517
Q2 2016 Presentation with appendix: http://www.roche.com/irp160721.pdf

Page 24: conversion rates for herceptin (47%) in 53 countries plus 3 in Q1 and mabthera (34%) in 16 countries plus Spain in Q1.

Things are moving a little slower with mabthera in terms of launched countries but conversion rate seems similar.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News